US 12,233,132 B2
Polyoxazoline-lipid conjugates and lipid nanoparticles and pharmaceutical compositions including same
J Milton Harris, Huntsville, AL (US); Michael Bentley, Huntsville, AL (US); Tacey Viegas, Madison, AL (US); Randall Moreadith, Huntsville, AL (US); Robert J Sharpe, Meridianville, AL (US); Kunsang Yoon, Madison, AL (US); Zhihao Fang, Madison, AL (US); and Rebecca Weimer, Huntsville, AL (US)
Assigned to Serina Therapeutics, Inc., Huntsville, AL (US)
Filed by Serina Therapeutics, Inc., Huntsville, AL (US)
Filed on Feb. 4, 2022, as Appl. No. 17/665,190.
Claims priority of provisional application 63/147,470, filed on Feb. 9, 2021.
Prior Publication US 2022/0249695 A1, Aug. 11, 2022
Int. Cl. A61K 47/69 (2017.01); A61K 39/00 (2006.01)
CPC A61K 47/6935 (2017.08) [A61K 39/00 (2013.01)] 22 Claims
 
1. A compound having one of the following formulae:

OG Complex Work Unit Chemistry
wherein m ranges from 0 to 2, n ranges from 1 to 1000, o ranges from 1 to 5, and p ranges from 1 to 10.